The Respiratory Devices Market size in Europe was worth USD 4.67 billion in 2020 and estimated to be growing at a CAGR of 9.47% to reach $7.34 billion by 2025.
Respiratory devices are devices used to support people suffering from respiratory problems and cannot achieve satisfactory oxygen levels to sustain life.
Respiratory diseases are the main cause of deaths globally. Lung infections like pneumonia and lung cancer, chronic obstructive pulmonary disease (COPD), and tuberculosis together accounted for around 12.5 million deaths globally during 2018, one-fifth of the worldwide total. These devices help exclude mucus from the respiratory airways and, in doing so, augment pulmonary function.
The rising aging population is one of the major drivers for the Respiratory Devices market in this region. Another aspect is that European countries face comparable economic and demographic burdens and share an interest in scrutinizing their impact on health outcomes nationally and across Europe. However, growing healthcare costs and the harmful effects of certain respiratory care devices on neonates are the main factors restraining the market's growth in this region.
This research report on the European Respiratory Devices Market has been segmented and sub-segmented into the following categories:
By Type:
By End User:
By Country:
Based on the end-user, the therapeutic devices segment leads to the global market. This is mainly due to the growing adoption of several therapeutic devices, such as nebulizers, humidifiers, and oxygen concentrators. Based on End Users, the European Respiratory Devices market is segmented into Hospitals and Home Care.
Geographically, the European market was the second-largest market with a global share of 27% in 2019. Germany is the largest market shareholder for the Respiratory Devices market in this region, followed by the UK and France. Other important markets in the region are Norway, Netherlands, Denmark, and Greece.
Key players operating in the Europe Respiratory Devices Market profiled in this report are Masimo Corporation, ResMed, Inc., Fisher and Paykel Healthcare Limited, Philips Healthcare, Covidien plc, and CareFusion Corporation.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Type
5.1.1 By Therapeutic Devices
5.1.1.1 BI-PAP Devices
5.1.1.2 Nebulizers
5.1.1.3 Ventilators
5.1.1.4 Resuscitators
5.1.1.5 CPAP Devices
5.1.1.6 Humidifiers
5.1.1.7 Oxygen Concentrators
5.1.1.8 Inhalers
5.1.2 By Diagnostic and Monitoring Devices
5.1.2.1 Sleep Test Devices
5.1.2.2 Pulse Oximeter
5.1.2.3 Spirometers
5.1.2.4 Peak Flow Meters
5.1.2.5 Capnographs
5.1.3 By Disposables
5.1.3.1 Cannulas
5.1.3.2 Filters
5.1.3.3 Masks
5.1.3.4 Tubes
5.1.3.5 Breathing Circuits
5.2 By End Users
5.2.1 Hospitals
5.2.2 Home Care
6. Geographical Analysis
6.1 Introduction
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Masimo Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 ResMed Inc.
8.3 Fisher and Paykel Healthcare Limited
8.4 Philips Healthcare
8.5 Covidien
8.6 CareFusion Corporation
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
